Turning Point Therapeutics Inc (TPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 25,205 | 0 | 25,000 | 0 | 0 |
| Gross Profit | 25,205 | N/A | 25,000 | N/A | N/A |
| Operating Expenses | 61,254 | 47,939 | 43,539 | 32,732 | 62,626 |
| Operating Income | -36,049 | -47,939 | -18,539 | -32,732 | -62,626 |
| Other Income | 545 | 563 | 834 | 1,239 | 1,908 |
| Pre-tax Income | -35,504 | -47,376 | -17,705 | -31,493 | -60,718 |
| Net Income Continuous | -35,504 | -47,376 | -17,705 | -31,493 | -60,718 |
| Net Income | $-35,504 | $-47,376 | $-17,705 | $-31,493 | $-60,718 |
| EPS Basic Total Ops | -0.73 | -0.92 | -0.42 | -0.82 | -1.69 |
| EPS Basic Continuous Ops | -0.73 | -0.93 | -0.42 | -0.82 | -1.69 |
| EPS Diluted Total Ops | -0.73 | -0.92 | -0.42 | -0.82 | -1.69 |
| EPS Diluted Continuous Ops | -0.73 | -0.93 | -0.42 | -0.82 | -1.69 |
| EPS Diluted Before Non-Recurring Items | -0.73 | -1.02 | -0.42 | N/A | N/A |
| EBITDA(a) | $-34,016 | $-46,246 | $-17,524 | $-32,132 | $-62,280 |